 We believe that the stock price of Ionis Pharmaceuticals, a biotech company that specializes in discovering and developing RNA-targeted therapeutics, is undervalued at current levels of under 37. IONS stock is down 11 from the levels of around 42 it was at on March 23, 2020. 